Genefron ^Company

Genefron Ltd., was established in 2011 to develop and manufacture unique diagnostic tests confronting the challenge of personalizing the medical treatments. The company is privately held by the founders and private investors.
Genefron addresses diagnostics of rheumatoid arthritis (RA), a long-term autoimmune disorder that is most frequent during middle age (35-50) and women are affected 2.5 times as frequently as men.